D'Ieteren Group NV
F:DJDA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D'Ieteren Group NV
F:DJDA
|
BE |
|
L
|
Lam Research Corp
DUS:LAR
|
US |
|
J
|
Jabil Inc
XMUN:JBL
|
US |
|
A
|
Akebia Therapeutics Inc
F:AX9
|
US |
|
R
|
Renaissancere Holdings Ltd
XBER:RRJ
|
BM |
|
Stadio Holdings Ltd
F:0JX
|
ZA |
|
C
|
Cigna Group
XMUN:CGN
|
US |
Wall St Price Targets
DJDA Price Targets Summary
D'Ieteren Group NV
According to Wall Street analysts, the average 1-year price target for DJDA is 213.68 EUR with a low forecast of 180.99 EUR and a high forecast of 262.86 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DJDA's stock price target?
Price Target
213.68
EUR
According to Wall Street analysts, the average 1-year price target for DJDA is 213.68 EUR with a low forecast of 180.99 EUR and a high forecast of 262.86 EUR.
What is the Revenue forecast for D'Ieteren Group NV?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 3 years is 9%.
What is the Operating Income forecast for D'Ieteren Group NV?
Projected CAGR
16%
Over the last 14 years, the compound annual growth rate for Operating Income has been -1%. The projected CAGR for the next 3 years is 16%.
What is the Net Income forecast for D'Ieteren Group NV?
Projected CAGR
31%
Over the last 14 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 3 years is 31%.
